首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Anti-thrombotic effect of combination of low molecular heparin and Xueshuantong after replantation of amputated finger
【24h】

Anti-thrombotic effect of combination of low molecular heparin and Xueshuantong after replantation of amputated finger

机译:低分子肝素与血栓通联合应用在断指再植后的抗血栓作用

获取原文
           

摘要

Purpose: To study the effects of low molecular heparin combined with Xueshuantong in preventing thrombosis after replantation of amputated finger. Methods: The treatment group (38 patients) was given 4500 IU of low molecular heparin sodium i.h. (hypodermic injection), q.d.(once daily), with 200 mL of 150 mg Xueshuantong injection and 5 % glucose injection, i.v.d. (intravenous drip), b.i.d. (twice daily). The control group received low molecular heparin sodium at 4500 IU i.h., q.d. alone. Treatment was for 3 days. Thereafter, D-dimer, fibrinogen, hemoglobin, platelets, prothrombin time (PT) and blood coagulation of patients in the 2 groups before and after treatment were compared. Differences in vasospasm, vascular thrombosis, finger necrosis, therapeutic effects and adverse reactions in patients in the 2 groups after treatment were recorded. Results: There were significant improvements in fibrinogen, platelet, PT levels, and blood coagulation time after treatment, with improvements better in the treatment group than in the control group (p 0.05). Vasospasm cases (3) were lower in the treatment group than in the control group (8, p 0.05), while vascular thrombosis and finger necrosis in both groups were comparable. Therapeutic effects and recovery were better in the treatment group than in the control group (p 0.05). Conclusion: Combined injection of Xueshuantong and low molecular heparin exerts antithrombotic effects after replantation of amputated finger, improves coagulation function, and reduces incidence of vasospasm. It has better therapeutic effects than low molecular heparin, and it seems safe.
机译:目的:研究低分子肝素联合血栓通预防断指再植后血栓形成的作用。方法:治疗组(38例)接受了4500 IU低分子肝素钠腹腔注射。 (皮下注射),每日一次(每日一次),以200毫升150毫克的血栓通注射液和5%的葡萄糖注射液进行。 (静脉滴注),b.i.d。 (每天两次)。对照组在i.h. q.d时以4,500 IU接受低分子肝素钠。单独。治疗持续3天。之后,比较两组患者治疗前后的D-二聚体,纤维蛋白原,血红蛋白,血小板,凝血酶原时间(PT)和凝血功能。记录两组治疗后患者的血管痉挛,血管血栓形成,手指坏死,治疗效果和不良反应的差异。结果:治疗后纤维蛋白原,血小板,PT水平和凝血时间均有显着改善,治疗组的改善优于对照组(p <0.05)。治疗组血管痉挛病例(3)低于对照组(8,p <0.05),而两组的血管血栓形成和手指坏死相当。治疗组的治疗效果和恢复优于对照组(p <0.05)。结论:血栓通与低分子肝素联合注射可在断指再植后发挥抗血栓作用,改善凝血功能,减少血管痉挛的发生。它比低分子肝素有更好的治疗效果,而且似乎很安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号